US FDA Sets Post-Pandemic Expectations For Manufacturer Remote Interactive Evaluations
Draft guidance outlines how the agency will use RIEs as COVID-19 becomes endemic and agency staff are generally able to travel for site inspections – and how manufacturing facilities should prepare for them.
